These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3151881)

  • 1. Changes in clearance of sodium valproate with changes in dose.
    Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
    Clin Exp Neurol; 1987; 24():97-103. PubMed ID: 3151881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
    Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
    Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
    Dutta S; Faught E; Limdi NA
    J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic drug monitoring of valproate].
    Bentué-Ferrer D; Tribut O; Verdier MC;
    Therapie; 2010; 65(3):233-40. PubMed ID: 20699076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
    Stockis A; Sargentini-Maier ML; Brodie MJ
    Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for estimating individualized valproate clearance values in children.
    Botha JH; Gray AL; Miller R
    J Clin Pharmacol; 1995 Oct; 35(10):1020-4. PubMed ID: 8568010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers.
    Vaz J; Kulkarni C; David J; Joseph T
    Indian J Exp Biol; 1998 Jan; 36(1):112-4. PubMed ID: 9536660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of difenin, valproate and phenobarbital on the development of an epileptiform seizure attack in Krushinskiĭ-Molodkina rats].
    Fedotova IB; Semiokhina AF; Fless DA; Arkhipova GV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(6):1104-8. PubMed ID: 9054163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.